Stryker (NYSE:SYK) Stock: Insider Ronda Stryker Sells 550,000 Shares

Stryker Corporation (NYSE:SYK) Director Ronda Stryker sold 550,000 shares of the business’s stock in a transaction on Friday, November 6th. The shares were sold at an average price of $325.32, for a total value of $178,926,000.00. Following the sale, the director owned 1,701,375 shares in the company, valued at approximately $553,491,315. The trade was a 24.43% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Stryker Price Performance

NYSE SYK traded down $0.17 during trading hours on Monday, hitting $325.69. The company had a trading volume of 2,551,435 shares, compared to its average volume of 2,514,437. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.30 and a current ratio of 2.18. The firm has a market capitalization of $123.99 billion, a price-to-earnings ratio of 34.69, a PEG ratio of 2.24 and a beta of 0.78. Stryker Corporation has a 52 week low of $267.00 and a 52 week high of $389.33. The firm has a 50 day simple moving average of $292.37 and a 200 day simple moving average of $323.59.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, October 29th. The medical technology company reported $3.52 earnings per share for the quarter, missing the consensus estimate of $3.55 by ($0.03). Stryker had a net margin of 13.78% and a return on equity of 23.74%. The company had revenue of $6.52 billion for the quarter, compared to the consensus estimate of $6.62 billion. During the same quarter in the prior year, the company earned $3.19 earnings per share. The company’s quarterly revenue was up 7.6% on a year-over-year basis. Equities research analysts expect that Stryker Corporation will post 14.84 earnings per share for the current year.

Hedge Funds Weigh In On Stryker

A number of hedge funds and other institutional investors have recently modified their holdings of SYK. Bank of America Corp DE purchased a new position in shares of Stryker during the second quarter worth approximately $1,404,284,000. Legal & General Group Plc purchased a new stake in shares of Stryker in the 2nd quarter valued at $707,212,000. Jupiter Topco LLC purchased a new stake in shares of Stryker in the 2nd quarter valued at $681,581,000. Corient Private Wealth LP bought a new position in shares of Stryker during the 2nd quarter valued at $323,035,000. Finally, Flossbach Von Storch SE bought a new position in shares of Stryker during the 2nd quarter valued at $464,506,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. TD Cowen decreased their target price on shares of Stryker from $298.00 to $290.00 and set a “hold” rating on the stock in a report on Friday, October 30th. Citigroup reissued a “market outperform” rating on shares of Stryker in a report on Friday, October 30th. JPMorgan Chase & Co. cut their price target on shares of Stryker from $350.00 to $340.00 and set an “overweight” rating for the company in a report on Friday, October 30th. Weiss Ratings restated a “hold (c)” rating on shares of Stryker in a research report on Thursday, October 29th. Finally, The Goldman Sachs Group decreased their price target on shares of Stryker from $363.00 to $339.00 and set a “neutral” rating on the stock in a report on Tuesday, July 14th. Twenty-one investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, Stryker currently has an average rating of “Moderate Buy” and a consensus target price of $342.19.

Stryker Company Profile

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings.

The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

Founded in 1941 by orthopedic surgeon Dr.